| 000 | 02823cam a22005538i 4500 | ||
|---|---|---|---|
| 001 | 9781003333319 | ||
| 003 | FlBoTFG | ||
| 005 | 20251030122237.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 230810s2023 flu ob 001 0 eng | ||
| 040 |
_aOCoLC-P _beng _erda _cOCoLC-P |
||
| 020 |
_a9781003333319 _q(ebook) |
||
| 020 | _a1003333311 | ||
| 020 |
_a9781000959802 _q(electronic bk. : EPUB) |
||
| 020 |
_a1000959805 _q(electronic bk. : EPUB) |
||
| 020 |
_a9781000959789 _q(electronic bk. : PDF) |
||
| 020 |
_a1000959783 _q(electronic bk. : PDF) |
||
| 020 |
_z9781032366937 _q(hardback) |
||
| 020 |
_z9781032366944 _q(paperback) |
||
| 024 | 7 |
_a10.1201/9781003333319 _2doi |
|
| 035 | _a(OCoLC)1394996626 | ||
| 035 | _a(OCoLC-P)1394996626 | ||
| 050 | 0 | 0 | _aQR186.6.P76 |
| 072 | 7 |
_aMED _x044000 _2bisacsh |
|
| 072 | 7 |
_aMED _x096000 _2bisacsh |
|
| 072 | 7 |
_aSCI _x049000 _2bisacsh |
|
| 072 | 7 |
_aMB _2bicssc |
|
| 100 | 1 |
_aSchein, Catherine H., _eauthor. _993699 |
|
| 245 | 1 | 0 |
_aConditionally toxic proteins / _cCatherine H. Schein. |
| 250 | _aFirst edition. | ||
| 264 | 1 |
_aBoca Raton, FL : _bCRC Press, _c2024. |
|
| 300 | _a1 online resource | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 520 |
_a"Human health depends upon access to high-quality proteins for our diet and pharmaceutical use. This book deals with the nature of toxicity as it applies to proteins in food and drugs. Many proteins, such as glutens and allergens, are valuable food sources but toxic for sensitized individuals. Even proteins produced in the human body can become toxic through mutation or aggregation. For example, Alzheimer and Huntington disease are characterized by plaques in the brain of insoluble protein aggregations. Paradoxically, even toxins produced by the most pathogenic microorganisms, such as Botox, have found use in the clinic and industry. This book discusses how many proteins, including interferons and cytokines, can be valuable therapeutics, and associated with autoimmune diseases, such as psoriasis or lupus erythematosus"-- _cProvided by publisher. |
||
| 588 | _aOCLC-licensed vendor bibliographic record. | ||
| 650 | 0 |
_aProteins _xImmunology. _993700 |
|
| 650 | 0 |
_aProteins _xToxicology. _993701 |
|
| 650 | 7 |
_aMEDICAL / Immunology _2bisacsh _993702 |
|
| 650 | 7 |
_aMEDICAL / Toxicology _2bisacsh _964900 |
|
| 650 | 7 |
_aSCIENCE / Life Sciences / Biology / Molecular Biology _2bisacsh _964014 |
|
| 856 | 4 | 0 |
_3Taylor & Francis _uhttps://www.taylorfrancis.com/books/9781003333319 |
| 856 | 4 | 2 |
_3OCLC metadata license agreement _uhttp://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf |
| 942 | _cE-Books | ||
| 999 |
_c67610 _d67610 |
||